
C7 Protein
For Research Use Only. Not for use in diagnostic procedures.
Purified human complement component C7. Complement component C7 is unique to the terminal complement pathway. It is a single chain protein with a molecular weight of 110 kD and is present in plasma at approximately 55 mg/L. Together with the other proteins of the terminal pathway, C7 forms the membrane attack complex or MAC.
All Quidel complement components are tested for functional activity in a standard lytic or applicable functional assay and for biochemical purity by SDS-polyacrylamide gel electrophoresis. Please refer to the Certificate of Analysis for lot specific information on functional titer.
Quidel's purified human complement components are useful in a wide variety of immunochemical and research applications. For assistance with a specific protocol, please contact Quidel Technical Support.
References
Nicholson-Weller, Butko, P, Wessels, M. Role of Complement Component C1q in IgG independent Opsonophagocytosis of Group B Streptococus, J. Immunol 163:2761-2768, 1999.
Barbashov, C., Wang C., Nicholson-Weller, A. Serum amyloid P component forms a stable complex with human C5b-6, J. Immunol. 158:3830-3835, 1997.
Koski, C., Dashell, S. Sublytic terminal complement complex decreases Po gene expression in schwan cells, J Neurochem 73(6):2321-2330, 1999.
Liu,C., et al. Interaction between the terminal complement pathway complex C5b-7 and anionic phospholipids, Blood 93(7)2291-2301, 1999.
Features & Benefits
Feature | Benefit |
---|
Product Specifications
Product Spec Name | Product Spec Data |
---|---|
Concentration | 1.0 mg/mL |
Volume/vial | 250 µL/vial |
Storage | At or below –70°C |
Purity | > 85% |
Buffer | PBS |
Ordering Information
Catalog Number | Kit Size / Case Size |
---|---|
A405 | 250 µL/vial |